(Q37869374)

24 August 2017

1 reference

title

The paradox of low BNP levels in obesity (English)

1 reference

24 August 2017

0 references

2

1 reference

24 August 2017

1

Aldo Clerico

1 reference

24 August 2017

4

Michele Emdin

1 reference

24 August 2017

3

Simona Vittorini

1 reference

PubMed ID

21523383

24 August 2017

language of work or name

1 reference

1 January 2012

1 reference

24 August 2017

Heart Failure Reviews

1 reference

24 August 2017

17

1 reference

24 August 2017

1

1 reference

24 August 2017

81-96

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-011-9249-z

24 August 2017

0 references

cites work

Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Impact of obesity on plasma natriuretic peptide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Association of plasma B-type natriuretic peptide levels with obesity in a general urban Japanese population: the Suita Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Obesity and suppressed B-type natriuretic peptide levels in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Relationship between obesity and B-type natriuretic peptide levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

N-terminal pro-B-type natriuretic Peptide in overweight and obese patients with and without diabetes: an analysis based on body mass index and left ventricular geometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Determinants of natriuretic peptide gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: is BNP or NT-proBNP a useful assessment tool?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Gene expression, processing, and secretion of natriuretic peptides: physiologic and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Cardiac natriuretic peptides gene expression and secretion in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Regulation and significance of atrial and brain natriuretic peptides as cardiac hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Chamber-dependent circadian expression of cardiac natriuretic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Angiotensin II-Induced Ventricular Hypertrophy and Extracellular Signal-Regulated Kinase Activation Are Suppressed in Mice Overexpressing Brain Natriuretic Peptide in Circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Fibrosis rather than blood pressure determines cardiac BNP expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Natriuretic peptides in unstable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Assay for measurement of intact B-type natriuretic peptide prohormone in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Pro-B-type natriuretic peptide levels in acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Analytical assay characterization for 1-108 pro-B-type natriuretic peptide on the BioPlex 2200 analyzer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Enzyme-linked immunoabsorbent assay for detection of human serine protease corin in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Estrogens and glucocorticoid hormones in adipose tissue metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Androgens and body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Estrogen, natriuretic peptides and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Long-term testosterone administration increases visceral fat in female to male transsexuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Testosterone and regional fat distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Effects of androgen therapy on adipose tissue and metabolism in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Contribution of age and declining androgen levels to features of the metabolic syndrome in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

The dark side of testosterone deficiency: III. Cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Testosterone deficiency, insulin resistance and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

A new role for the natriuretic peptides: metabolic regulators of the adipocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Expression and secretion of the atrial natriuretic peptide in human adipose tissue and preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Control of lipolysis by natriuretic peptides and cyclic GMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Direct effects of high glucose and insulin on protein synthesis in cultured cardiac myocytes and DNA and collagen synthesis in cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Lipotoxicity in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Cardiac adiposity and global cardiometabolic risk: new concept and clinical implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Adipose tissue: the new endocrine organ? A review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage--mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Leptin exerts an anti-apoptotic effect on human dendritic cells via the PI3K-Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-kappaB/p300 binding in human synovial fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated k

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Enhanced hypertrophy in ob/ob mice due to an impairment in expression of atrial natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Leptin reduces plasma ANP level via nitric oxide-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Inhibition of leptin release by atrial natriuretic peptide (ANP) in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Coronary heart disease and body fat distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Impact of age and sex on plasma natriuretic peptide levels in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

B-type natriuretic peptide levels in obese patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Amino-terminal pro-brain natriuretic Peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Gender dimorphic associations between N-terminal pro-brain natriuretic peptide, body mass index and blood pressure in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Incremental prognostic value of changes in B-type natriuretic peptide in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

B-type natriuretic peptide-guided heart failure therapy: A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

The cost of dichotomising continuous variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Assessment methods in human body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

The relationship between body mass index/body composition and survival in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Body mass index and mortality in heart failure: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Reverse epidemiology: a spurious hypothesis or a hardcore reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Quality specifications for B-type natriuretic peptide assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Evidence for functional heterogeneity of circulating B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Nutritional and anti-inflammatory interventions in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Proinflammatory cytokines in heart failure: double-edged swords

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Testosterone deficiency: a common, unrecognized syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Relation of B-type natriuretic peptide levels to body mass index after comprehensive lifestyle changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Plasma natriuretic peptide levels and the risk of cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Brain natriuretic peptide predicts mortality in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Gender-specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortality in the Japanese general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Characteristics and 1-year prognosis of medically treated patients with chronic heart failure in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Natriuretic peptides for risk stratification of patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

The human disease network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

The implications of human metabolic network topology for disease comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

The obesity paradox and outcome in heart failure: is excess bodyweight truly protective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9249-Z

Scale-free networks: a decade and beyond

21 January 2018

1 reference

12 December 2020

Atherogenic effects of anabolic steroids on serum lipid levels. A literature review

1 reference

12 December 2020

Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women

1 reference

12 December 2020

Atrial natriuretic factor: a hormone produced by the heart

1 reference

12 December 2020

Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium.

1 reference

12 December 2020

Visceral fat is negatively associated with B-type natriuretic peptide levels in patients with advanced type 2 diabetes

1 reference

12 December 2020

BNP in overweight and obese patients with heart failure: an analysis based on the BNP-LV diastolic wall stress relationship

1 reference

12 December 2020

Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observat

1 reference

12 December 2020

Peptide hormones and their prohormones as biomarkers

1 reference

12 December 2020

Prediction of in-hospital mortality by brain natriuretic peptide levels and other independent variables in acutely ill patients with suspected heart disease

1 reference

12 December 2020

Network medicine--from obesity to the "diseasome"

1 reference

12 December 2020

Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome

1 reference

12 December 2020

Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men

1 reference

12 December 2020

Usefulness of plasma N-terminal proatrial natriuretic peptide (proANP) as an early predictor of outcome in unstable angina pectoris or non-ST-elevation acute myocardial infarction

1 reference

12 December 2020

Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure.

1 reference

12 December 2020

Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells: its role in MMP-2/9 production and activation

1 reference

12 December 2020

Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: the need for a new generation of immunoassay methods.

1 reference

12 December 2020

Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency

1 reference

12 December 2020

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)

1 reference

12 December 2020

Mechanical and neuroendocrine regulation of the endocrine heart.

1 reference

12 December 2020

Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals.

1 reference

12 December 2020

Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction

1 reference

12 December 2020

The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects.

1 reference

12 December 2020

The physiological and pathophysiological modulation of the endocrine function of the heart

1 reference

12 December 2020

Biosynthesis of cardiac natriuretic peptides

1 reference

12 December 2020

Salt-regulating hormones in young normotensive obese subjects. Effects of saline load

1 reference

12 December 2020

Natriuretic peptide assays revisited: do we need pro-B-type natriuretic peptide?

1 reference

12 December 2020

Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure.

1 reference

12 December 2020

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

12 December 2020

Acute myocardial hypoxia increases BNP gene expression.

1 reference

12 December 2020

Dichotomizing continuous predictors in multiple regression: a bad idea

1 reference

12 December 2020

Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output

1 reference

12 December 2020

Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction

1 reference

12 December 2020

10.1007/S10741-011-9249-Z

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21523383